EPCAM and neoplasm: An example of bispecific antibodies is catumaxomab, which can simultaneously activate innate immune cells via the fragment crystallizable region (Fc region) and bind to CD3 in the TCR complex and epithelial cell adhesion molecule (EpCAM) is a tumor antigen, inducing a robust antitumor immune response.[116]